Nischalan Pillay

20.1k total citations
45 papers, 1.6k citations indexed

About

Nischalan Pillay is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Nischalan Pillay has authored 45 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 18 papers in Cancer Research and 17 papers in Molecular Biology. Recurrent topics in Nischalan Pillay's work include Sarcoma Diagnosis and Treatment (24 papers), Cancer Genomics and Diagnostics (12 papers) and Bone Tumor Diagnosis and Treatments (11 papers). Nischalan Pillay is often cited by papers focused on Sarcoma Diagnosis and Treatment (24 papers), Cancer Genomics and Diagnostics (12 papers) and Bone Tumor Diagnosis and Treatments (11 papers). Nischalan Pillay collaborates with scholars based in United Kingdom, United States and Switzerland. Nischalan Pillay's co-authors include Adrienne M. Flanagan, Roberto Tirabosco, Hongtao Ye, Fernanda Amary, Nadège Presneau, Fitim Berisha, Christopher D. Steele, Daniel Baumhoer, Dina Halai and Stephen Henderson and has published in prestigious journals such as Nature, Nature Communications and Nature Genetics.

In The Last Decade

Nischalan Pillay

44 papers receiving 1.6k citations

Peers

Countries citing papers authored by Nischalan Pillay

Since Specialization

Citations

This map shows the geographic impact of Nischalan Pillay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nischalan Pillay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nischalan Pillay more than expected).

Fields of papers citing papers by Nischalan Pillay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nischalan Pillay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nischalan Pillay. The network helps show where Nischalan Pillay may publish in the future.

Co-authorship network of co-authors of Nischalan Pillay

This figure shows the co-authorship network connecting the top 25 collaborators of Nischalan Pillay. A scholar is included among the top collaborators of Nischalan Pillay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nischalan Pillay. Nischalan Pillay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	HRProfiler Detects Homologous Recombination Deficiency in Breast and Ovarian Cancers Using Whole-Genome and Whole-Exome Sequencing Data 2025 ·Cancer Research ·Ammal Abbasi, Christopher D. Steele, Erik N. Bergstrom, Azhar Khandekar, (unknown), Rana R. McKay, Nischalan Pillay, Ludmil B. Alexandrov	2
2	The History of Chromosomal Instability in Genome-Doubled Tumors 2024 ·Cancer Discovery ·Toby M. Baker, (unknown), (unknown), Tom Lesluyes, Haixi Yan, Huw A. Ogilvie, Annelien Verfaillie, Stefan C. Dentro, Amy L. Bowes, Nischalan Pillay, Adrienne M. Flanagan, Charles Swanton, Paul T. Spellman, Maxime Tarabichi, Peter Van Loo	1
3	Transcriptomic profiles of myxofibrosarcoma and undifferentiated pleomorphic sarcoma correlate with clinical and genomic features 2024 ·The Journal of Pathology ·Shamik Mitra, (unknown), Paul Piccinelli, (unknown), Asle C. Hesla, (unknown), Fredrik Vult von Steyern, (unknown), Mikael Eriksson, Linda Magnusson, (unknown), Nischalan Pillay, Fredrik Mertens	2
4	Visualizing and exploring patterns of large mutational events with SigProfilerMatrixGenerator 2023 ·BMC Genomics ·Azhar Khandekar, Raviteja Vangara, Mark Barnes, Marcos Díaz‐Gay, Ammal Abbasi, Erik N. Bergstrom, Christopher D. Steele, Nischalan Pillay, Ludmil B. Alexandrov	10
5	Mapping clustered mutations in cancer reveals APOBEC3 mutagenesis of ecDNA 2022 ·Nature ·Erik N. Bergstrom, Jens Luebeck, Mia Petljak, Azhar Khandekar, Mark Barnes, Tongwu Zhang, Christopher D. Steele, Nischalan Pillay, Maria Teresa Landi, Vineet Bafna, Paul S. Mischel, Reuben S. Harris, Ludmil B. Alexandrov	90
6	Overlapping morphological, immunohistochemical and genetic features of superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor 2021 ·Modern Pathology ·Florian Puls, Jodi M. Carter, Nischalan Pillay, Thomas A. McCulloch, Vaiyapuri P. Sumathi, Pehr Rissler, Henrik Fagman, Magnus Hansson, Fernanda Amary, Roberto Tirabosco, Linda Magnusson, Jenny Nilsson, Adrienne M. Flanagan, Andrew L. Folpe, Fredrik Mertens	19
7	Therapeutic vulnerability to PARP1,2 inhibition in RB1-mutant osteosarcoma 2021 ·Nature Communications ·Georgia Zoumpoulidou, (unknown), Caterina Mancusi, (unknown), (unknown), Christopher D. Steele, Maxime Tarabichi, (unknown), (unknown), (unknown), (unknown), Katia Scotlandi, Nischalan Pillay, Sandra J. Strauss, Sibylle Mittnacht	28
8	Inhibition of Histone H3K27 Demethylases Inactivates Brachyury (TBXT) and Promotes Chordoma Cell Death 2020 ·Cancer Research ·Lucia Cottone, Adam P. Cribbs, Garima Khandelwal, Graham Wells, (unknown), Martin Philpott, Anthony Tumber, Patrick Lombard, Edward S. Hookway, Tamás Szommer, C. Johansson, Paul E. Brennan, Nischalan Pillay, Richard G. Jenner, Udo Oppermann, Adrienne M. Flanagan	35
9	Genomics of MPNST (GeM) Consortium: Rationale and Study Design for Multi-Omic Characterization of NF1-Associated and Sporadic MPNSTs 2020 ·Genes ·David T. Miller, Isidro Cortés‐Ciriano, Nischalan Pillay, Angela C. Hirbe, Matija Snuderl, Marilyn M. Bui, (unknown), Alyaa Al‐Ibraheemi, Brendan C. Dickson, Jesse Hart, Kevin B. Jones, Justin T. Jordan, Raymond H. Kim, Daniel Lindsay, Yoshihiro Nishida, Nicole J. Ullrich, Xia Wang, Peter J. Park, Adrienne M. Flanagan	13
10	Sarcoma and the 100,000 Genomes Project: our experience and changes to practice 2020 ·The Journal of Pathology Clinical Research ·(unknown), (unknown), William Cross, Nischalan Pillay, Sandra J. Strauss, Hongtao Ye, Daniel Lindsay, Roberto Tirabosco, Jane Chalker, Shazia Mahamdallie, Alona Sosinsky, Adrienne M. Flanagan, Fernanda Amary	24
11	CM-Path Molecular Diagnostics Forum—consensus statement on the development and implementation of molecular diagnostic tests in the United Kingdom 2019 ·British Journal of Cancer ·(unknown), Philip S. Macklin, Nischalan Pillay, Jessica Lee, (unknown), Sophie K. Scott, (unknown), C. E. H. Craig, J. Louise Jones, Karin A. Oien, Richard Colling, Sarah E. Coupland, Clare Verrill	3
12	Synovial chondromatosis and soft tissue chondroma: extraosseous cartilaginous tumor defined by FN1 gene rearrangement 2019 ·Modern Pathology ·Fernanda Amary, (unknown), Hongtao Ye, Lucia Cottone, (unknown), Paul Cool, Elena Miranda, Fitim Berisha, William Aston, (unknown), Paul O’Donnell, Nischalan Pillay, Roberto Tirabosco, Daniel Baumhoer, Edward S. Hookway, Adrienne M. Flanagan	64
13	ANNOUNCE 2: An open-label phase 1b, and a randomized, double-blind phase 2 study of olaratumab with gemcitabine plus docetaxel in the treatment of patients with advanced soft tissue sarcoma (STS) 2016 ·Annals of Oncology ·Andrés Redondo, (unknown), Nadia Hindi, José A. López-Martín, (unknown), Yi Zeng, (unknown), (unknown), Gary Mo, Robert Ilaria, Nischalan Pillay, (unknown), (unknown)	1
14	GNAS mutations are not detected in parosteal and low-grade central osteosarcomas 2015 ·Modern Pathology ·Carolina Salinas-Souza, Carlos de Andrea, Michel Bihl, Michal Kováč, Nischalan Pillay, Tim Forshew, Alice Gutteridge, Hongtao Ye, Fernanda Amary, Roberto Tirabosco, Sílvia Regina Caminada de Toledo, Daniel Baumhoer, Adrienne M. Flanagan	33
15	Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer 2014 ·Investigational New Drugs ·Jordi Rodón, Michael A. Carducci, Juan Manuel Sepúlveda-Sánchez, Analía Azaro, Emiliano Calvo, Joan Seoane, Irene Braña, Elisabet Sicart, Ivelina Gueorguieva, Ann Cleverly, Nischalan Pillay, D. Desaiah, Shawn T. Estrem, Luis Paz‐Ares, Matthias Holdhoff, Jaishri O. Blakeley, Michael Lahn, José Baselga	91
16	The G-Protein–Coupled Receptor CLR Is Upregulated in an Autocrine Loop with Adrenomedullin in Clear Cell Renal Cell Carcinoma and Associated with Poor Prognosis 2013 ·Clinical Cancer Research ·Leonid L. Nikitenko, Russell Leek, Stephen Henderson, Nischalan Pillay, Helen Turley, Daniele Generali, Sarah Gunningham, Helen Morrin, Andrea Pellagatti, Margaret Rees, Adrian L. Harris, Stephen B. Fox	16
17	Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumors 2013 ·Genome Medicine ·Matthias Lechner, Garrett M. Frampton, Tim R. Fenton, Andrew Feber, Gary A. Palmer, Amrita Jay, Nischalan Pillay, Martin Förster, Maureen Cronin, Doron Lipson, Vincent A. Miller, Timothy Brennan, Stephen Henderson, Francis Vaz, Paul O’Flynn, Nicholas Kalavrezos, Roman Yelensky, Stephan Beck, Philip J. Stephens, Chris Boshoff	169
18	An integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordoma 2012 ·The Journal of Pathology ·Andrew C. Nelson, Nischalan Pillay, Stephen Henderson, Nadège Presneau, Roberto Tirabosco, Dina Halai, Fitim Berisha, Paul Flicek, Derek L. Stemple, Claudio D. Stern, Fiona C. Wardle, Adrienne M. Flanagan	70
19	A common single-nucleotide variant in T is strongly associated with chordoma 2012 ·Nature Genetics ·Nischalan Pillay, Vincent Plagnol, Patrick Tarpey, Samira Lobo, Nadège Presneau, Károly Szuhai, Dina Halai, Fitim Berisha, Stephen R. Cannon, Simon Mead, Dalia Kasperavičiūtė, Jutta Palmen, Philippa J. Talmud, Lars‐Gunnar Kindblom, Maria Fernanda Amary, Roberto Tirabosco, Adrienne M. Flanagan	92
20	Mucinous tubular and spindle cell carcinoma with aggressive histomorphology—a sarcomatoid variant 2008 ·Human Pathology ·Nischalan Pillay, Pratistadevi K. Ramdial, Kumarasen Cooper, (unknown)	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact